These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11049015)

  • 1. Consequences of a change in reimbursement status on prescription patterns.
    Bouvy ML; Egberts TC
    Eur J Clin Pharmacol; 2000 Sep; 56(6-7):511-2. PubMed ID: 11049015
    [No Abstract]   [Full Text] [Related]  

  • 2. Ahh-choo! How to sneeze at allergies.
    Consum Rep; 2010 May; 75(5):7. PubMed ID: 20419895
    [No Abstract]   [Full Text] [Related]  

  • 3. Central nervous system effects of H1-receptor antagonists in the elderly.
    Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetirizine and loratadine: a comparison using the ED50 in skin reactions.
    Ramboer I; Bumtbacea R; Lazarescu D; Radu JR
    J Int Med Res; 2000; 28(2):69-77. PubMed ID: 10898119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of the skin blood flow response to histamine. Comparison of the effects of cetirizine and loratadine on the skin response to a histamine dry prick test monitored with laser-Doppler flowmetry.
    Van Neste D; Rihoux JP
    Dermatology; 1993; 186(4):281-3. PubMed ID: 8099818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
    Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl.
    Kontou-Fili K; Paleologos G; Herakleous M
    Eur J Clin Pharmacol; 1989; 36(6):617-9. PubMed ID: 2570701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
    Llupià J; Gras J; Llenas J
    Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
    Clough GF; Bennett AR; Church MK
    Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
    Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a new generation of H1 antihistamines (cetirizine and loratadine) on histamine release and the bronchial response to histamine in atopic patients.
    Chyrek-Borowska S; Siergiejko Z; Michalska I
    J Investig Allergol Clin Immunol; 1995; 5(2):103-7. PubMed ID: 7655699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in H1-receptor antagonist treatment.
    Simons FE
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W; Warrington S; Boyce M; Luria X
    Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
    Spencer HM
    Am Univ Law Rev; 2002 Jun; 51(5):999-1050. PubMed ID: 12197546
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe adverse effect of the anti-allergy drug loratadine--warning against prolonged use of non-prescription drugs].
    Nyman K; Bergman U
    Lakartidningen; 1992 Jun; 89(25):2281. PubMed ID: 1352839
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.